dont get me wrong... i really enjoy the CUV story and I am not selling... but I am annoyed that the price jumped possibly unwarranted. I would really like some non financial metrics.
A big difference with SRX is that is is one of many possible treatments available to a much larger population... where as CUV is the only treatment although targeted at a much smaller audience.
I would like to be still owning CUV shares in 3 to 5 years time... but I suspect they would be taken over before then.
cuv101... it did cross my mind that SRX is possibly too cheap when i did this analysis... but i havent looked at it closely for about 2 years...
Still Undervalued, page-22
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.74 |
Change
0.190(1.31%) |
Mkt cap ! $738.1M | |||
| Open | High | Low | Value | Volume |
| $14.60 | $14.79 | $14.32 | $881.1K | 60.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87 | $14.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |